Australian Pharma Industries Ltd (API)

Sydney

Currency in AUD

1.530

0.000(0.00%)

Closed22/03

Fair Value

Day's Range

1.528

1.530

52 wk Range

1.528

1.530

API Income Statement

Featured here, the Income Statement (earnings report) for Australian Pharma Industries Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2012

31/08

2013

31/08

2014

31/08

2015

31/08

2016

31/08

2017

31/08

2018

31/08

2019

31/08

2020

31/08

2021

31/08

Total Revenues

4,061.2

4,026.3

4,010.73

4,019.53

4,004.86

Total Revenues Growth

+5.76%

-0.86%

-0.39%

+0.22%

-0.36%

Cost Of Revenues

3,567.57

3,529.59

3,492.42

3,539.05

3,501.89

Gross Profit

493.63

496.71

518.31

480.47

502.97

Gross Profit Growth

+3.28%

+0.62%

+4.35%

-7.3%

+4.68%

Gross Profit Margin %

12.15%

12.34%

12.92%

11.95%

12.56%

Other Operating Expenses, Total

410.31

423.2

433.75

426.72

439.38

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+4.74%	+3.14%	+2.49%	-1.62%	+2.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	410.31	423.2	451.78	434.2	440.71
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-18.03	-7.48	-1.33

Operating Income

83.32

73.51

84.56

53.75

63.59

Operating Income Growth

-3.34%

-11.77%

+15.03%

-36.43%

+18.3%

EBIT Margin %

2.05%

1.83%

2.11%

1.34%

1.59%

Net Interest Expenses

-2.02

1.23

-2.91

-6.17

-8.23

Net Interest Expenses Growth

+74.81%

+160.89%

-337.16%

-111.99%

-33.43%

Interest Expense, Total

-8.3

-7.84

-12.6

-13.05

-10.29

Interest And Investment Income

6.29

9.07

9.69

6.88

2.06

Other Non Operating Expenses, Total

-4.94

-4.71

-8.16

-5.98

-5.19

EBT, Excl. Unusual Items

76.36

70.03

73.49

41.6

50.17

Gain (Loss) On Sale Of Assets

0.05

-

0.25

0.06

2.71

Other Unusual Items, Total

-

-

-

-37.5

-

EBT, Incl. Unusual Items

76.41

70.03

73.74

-13.46

12.46

EBT, Incl. Unusual Items Growth

+10.89%

-8.36%

+5.3%

-118.25%

+192.59%

EBT, Incl. Unusual Items Margin

1.88%

1.74%

1.84%

-0.33%

0.31%

Income Tax Expense

24.04

21.83

17.16

-6.35

11.32

Net Income to Company

52.37

48.2

56.58

-7.11

1.15

Minority Interest

-

-0.15

-1.47

-0.46

0.23

Net Income

52.37

48.06

55.11

-7.56

1.38

Net Income Growth

+1.36%

-8.24%

+14.68%

-113.73%

+118.2%

Net Income Margin %

1.29%

1.19%

1.37%

-0.19%

0.03%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

52.37

48.06

55.11

-7.56

1.38

Basic EPS - Continuing Operations

0.11

0.1

0.11

-0.02

0

Basic EPS - Continuing Operations Growth

+1.19%

-8.66%

+14.55%

-113.72%

+118.2%

Diluted EPS - Continuing Operations

0.11

0.1

0.11

-0.02

0

Diluted EPS - Continuing Operations Growth

+0.95%

-8.49%

+14.43%

-113.83%

+118.2%

Basic Weighted Average Shares Outstanding

489.7

491.98

492.52

492.63

492.66

Diluted Weighted Average Shares Outstanding

494.64

494.66

496.05

496.63

498.07

Dividend Per Share

0.07

0.08

0.08

0.02

0.04

Dividend Per Share Growth

+16.67%

+7.14%

+3.33%

-74.19%

+75%

EBITDA

100.36

90.27

102.07

71.49

80.97

EBITDA Growth

-2.36%

-10.05%

+13.07%

-29.96%

+13.25%

EBITDA Margin %

2.47%

2.24%

2.54%

1.78%

2.02%

EBIT